Viewing Study NCT04402957


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-20 @ 1:45 PM
Study NCT ID: NCT04402957
Status: COMPLETED
Last Update Posted: 2025-07-09
First Post: 2020-05-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
Sponsor: Arch Biopartners Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID View
None Severe Acute Respiratory Syndrome View
None Sars-CoV2 View
None Acute Kidney Injury View
None Acute Respiratory Distress Syndrome View
Keywords: